Physician profile
Robert E Jock
NPI 1548542178
$948.68
in general payments reported to CMS, 2019-2025
11 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $410 · 2023: $117 · 2024: $316 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $539.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $227.13 | 2022-2024 | Mymobility Platform |
| Amgen INC. | $211.14 | 2024-2025 | Evenity |
| Abbott Laboratories | $209.91 | 2022 | |
| Ferring Pharmaceuticals INC. | $86.25 | 2022-2025 | Euflexxa |
| Davol INC. | $53.23 | 2024 | Arista Ah Flexitip |
| Heron Therapeutics, INC. | $43.24 | 2023-2024 | Zynrelef, Aponvie |
| Fidia Pharma USA INC. | $37.27 | 2022-2023 | Triluron, Hymovis |
| Ethicon US, LLC | $29.68 | 2022 | |
| Abbvie INC. | $23.22 | 2023 | |
| Smith+Nephew, INC. | $14.52 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.